Literature DB >> 15085283

[Mesohepatectomy-an alternative to extended hepatectomy in the treatment of central liver tumors].

H Lang1, G C Sotiropoulos, N R Frühauf, A Radtke, M Malagó, Ch E Broelsch.   

Abstract

Mesohepatectomy was performed in seven patients with a primary or secondary central liver tumor. We describe the surgical procedure for mesohepatectomy (removal of segments IVa/IVb/V/VIII +/- I) in the treatment of central hepatic tumors. This technically demanding but safe approach requires careful vascular dissection to maintain blood supply and venous drainage of the two remaining liver parts. Mesohepatectomy results in one or two large resection planes bearing a considerable risk of parenchymal necrosis or biliary leakage. Its major advantage over extended hepatectomy is the preservation of functioning liver tissue. Thus, the risk of postoperative liver failure is reduced and, in case of intrahepatic recurrence, the chance for repeat hepatectomy improved. Mesohepatectomy should be considered in selected cases of central liver tumors in which extended resection would be associated with a high risk of liver insufficiency.

Entities:  

Mesh:

Year:  2004        PMID: 15085283     DOI: 10.1007/s00104-003-0803-7

Source DB:  PubMed          Journal:  Chirurg        ISSN: 0009-4722            Impact factor:   0.955


  32 in total

1.  Extended resection for intrahepatic cholangiocarcinoma in Japan.

Authors:  M Yamamoto; K Takasaki; T Yoshikawa
Journal:  J Hepatobiliary Pancreat Surg       Date:  1999

2.  Mesohepatectomy.

Authors:  C H Scudamore; A K Buczkowski; H Shayan; S G Ho; G M Legiehn; S W Chung; D A Owen
Journal:  Am J Surg       Date:  2000-05       Impact factor: 2.565

3.  Efficacy and safety of preoperative percutaneous transhepatic portal embolization with absolute ethanol: a clinical study.

Authors:  T Shimamura; Y Nakajima; Y Une; T Namieno; K Ogasawara; K Yamashita; T Haneda; K Nakanishi; J Kimura; M Matsushita; N Sato; J Uchino
Journal:  Surgery       Date:  1997-02       Impact factor: 3.982

4.  Significance of resection margin in hepatectomy for hepatocellular carcinoma: A critical reappraisal.

Authors:  R T Poon; S T Fan; I O Ng; J Wong
Journal:  Ann Surg       Date:  2000-04       Impact factor: 12.969

5.  Right trisectionectomy for primary liver cancer.

Authors:  Jing-An Rui; Shao-Bin Wang; Shu-Guang Chen; Li Zhou
Journal:  World J Gastroenterol       Date:  2003-04       Impact factor: 5.742

Review 6.  [Anatomical and atypical liver resections].

Authors:  J Scheele
Journal:  Chirurg       Date:  2001-02       Impact factor: 0.955

7.  Treatment of centrally located hepatocellular carcinoma with central hepatectomy.

Authors:  Rey-Heng Hu; Po-Huang Lee; Yue-Cune Chang; Ming-Chih Ho; Sen-Chang Yu
Journal:  Surgery       Date:  2003-03       Impact factor: 3.982

8.  Preoperative portal vein embolization for extended hepatectomy.

Authors:  Alan W Hemming; Alan I Reed; Richard J Howard; Shiro Fujita; Steven N Hochwald; James G Caridi; Irvin F Hawkins; Jean-Nicolas Vauthey
Journal:  Ann Surg       Date:  2003-05       Impact factor: 12.969

9.  The small remnant liver after major liver resection: how common and how relevant?

Authors:  Cengizhan Yigitler; Olivier Farges; Reza Kianmanesh; Jean-Marc Regimbeau; Eddie K Abdalla; Jacques Belghiti
Journal:  Liver Transpl       Date:  2003-09       Impact factor: 5.799

10.  Portal vein embolization vs. portal vein ligation for induction of hypertrophy of the future liver remnant.

Authors:  Dieter C Broering; Christian Hillert; Gerrit Krupski; Lutz Fischer; Lars Mueller; Eike G Achilles; Jan Schulte am Esch; Xavier Rogiers
Journal:  J Gastrointest Surg       Date:  2002 Nov-Dec       Impact factor: 3.267

View more
  2 in total

Review 1.  [Resection of Klatskin tumors].

Authors:  D Seehofer; C Kamphues; P Neuhaus
Journal:  Chirurg       Date:  2012-03       Impact factor: 0.955

Review 2.  [Liver resection: prt II. Operative procedure].

Authors:  H Lang
Journal:  Chirurg       Date:  2007-09       Impact factor: 0.955

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.